XDH Antibody - #DF8111

>>买2送1 进行中>>
>>赠JD卡 进行中>>
(4)   (7)  
产品: XDH 抗体
货号: DF8111
描述: Rabbit polyclonal antibody to XDH
应用: WB IHC
文献验证: WB, IHC
反应: Human, Rat
预测: Pig, Bovine, Sheep, Rabbit, Dog, Chicken
蛋白号: P47989
RRID: AB_2841454

浏览相似产品>>

   规格 价格 库存
 50ul RMB¥ 1250 现货
 100ul RMB¥ 2300 现货
 200ul RMB¥ 3000 现货

货期: 当天发货

联系销售
相关下载
MS Report
HPLC Report
MSDS
说明书
COA
实验方案
WB Handbook
IHC Protocol
IF/ICC Protocol

产品描述

来源:
Rabbit
应用:
WB 1:1000-3000, IHC 1:50-1:200
*The optimal dilutions should be determined by the end user.
*Tips:

WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.

反应:
Human, Rat
克隆:
Polyclonal
特异性:
XDH Antibody detects endogenous levels of total XDH.
RRID:
AB_2841454
引用格式: Affinity Biosciences Cat# DF8111, RRID:AB_2841454.
偶联:
Unconjugated.
纯化:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
别名:

展开/折叠

Xanthine dehydrogenase; Xanthine dehydrogenase/oxidase; Xanthine oxidase; Xanthine oxidoreductase; XD; XDH; XDH_HUMAN; xdha; XO; xor;

抗原和靶标

免疫原:

A synthesized peptide derived from human XDH, corresponding to a region within the internal amino acids.

基因/基因ID:
XDH(7498)

研究领域

· Cellular Processes > Transport and catabolism > Peroxisome.   (View pathway)

· Metabolism > Nucleotide metabolism > Purine metabolism.

· Metabolism > Biosynthesis of other secondary metabolites > Caffeine metabolism.

· Metabolism > Xenobiotics biodegradation and metabolism > Drug metabolism - other enzymes.

· Metabolism > Global and overview maps > Metabolic pathways.

文献引用

1). Sesamol supplementation alleviates nonalcoholic steatohepatitis and atherosclerosis in high-fat, high carbohydrate and high-cholesterol diet-fed rats. Food & Function, 2021 (PubMed: 34606548) [IF=5.1]

Application: WB    Species: Rat    Sample: liver tissue

Fig. 6 Sesamol decreased uric acid levels through the inhibition of XO activity and/or its expression in HF-HCC diet-fed rats. (A–D) The analyses of serum and hepatic XO activities and uric acid levels (samples from 6 rats in each group were analyzed). (E) Representative images of the western blot analysis from hepatic XO expression, and (F) representative images of the IHC analyses from hepatic XO expression (samples from 3 rats in each group were analyzed). Values are expressed as means ± SEM (n = 6); #P < 0.05, # #P < 0.01 and ###P < 0.001, versus control; *P < 0.05 and **P < 0.01, versus HF-HCC.

Application: IHC    Species: Rat    Sample: liver tissue

Fig. 6 Sesamol decreased uric acid levels through the inhibition of XO activity and/or its expression in HF-HCC diet-fed rats. (A–D) The analyses of serum and hepatic XO activities and uric acid levels (samples from 6 rats in each group were analyzed). (E) Representative images of the western blot analysis from hepatic XO expression, and (F) representative images of the IHC analyses from hepatic XO expression (samples from 3 rats in each group were analyzed). Values are expressed as means ± SEM (n = 6); #P < 0.05, # #P < 0.01 and ###P < 0.001, versus control; *P < 0.05 and **P < 0.01, versus HF-HCC.

Application: WB    Species: Rat    Sample:

Fig. 6 Sesamol decreased uric acid levels through the inhibition of XO activity and/or its expression in HF-HCC diet-fed rats. (A–D) The analyses of serum and hepatic XO activities and uric acid levels (samples from 6 rats in each group were analyzed). (E) Representative images of the western blot analysis from hepatic XO expression, and (F) representative images of the IHC analyses from hepatic XO expression (samples from 3 rats in each group were analyzed). Values are expressed as means ± SEM (n = 6); # P < 0.05, # # P < 0.01 and # # # P < 0.001, versus control; *P < 0.05 and **P < 0.01, versus HF-HCC.
2). Polysaccharide extracted from Phellinus igniarius attenuated hyperuricemia by modulating bile acid metabolism and inhibiting uric acid synthesis in adenine/potassium oxonate-treated mice. Journal of ethnopharmacology, 2025 (PubMed: 39837359) [IF=4.8]
3). Potential candidates from a functional food Zanthoxyli Pericarpium (Sichuan pepper) for the management of hyperuricemia: high-through virtual screening, network pharmacology and dynamics simulations. Frontiers in endocrinology, 2024 (PubMed: 39722812) [IF=3.9]

Application: WB    Species: human    Sample:

Figure 8. CESTA for interaction between 2’-methylacetophenone and XDH. (A) A representative graph of CETSA and (B) the density of the bands were measured and shown as a line chart. Values are expressed as mean ±SEM (n = 3). (C) 2’-methylacetophenone and XDH molecular docking of the most fit predictive pocket schematic, via CB-Dcok2.
4). C1QBP regulates apoptosis of renal cell carcinoma via modulating xanthine dehydrogenase (XDH) mediated ROS generation. International Journal of Medical Sciences, 2022 (PubMed: 35693733) [IF=3.2]

Application: WB    Species: Human    Sample: ACHN and 786-O cells

Figure 2 C1QBP regulates the expression of XDH in RCC. (A) Western blot detected the expression of XDH in ACHN and 786-O cells with stable C1QBP knockdown (left panel) and C1QBP overexpression (right panel). (B) The XDH mRNA was examined by qRT-PCR in ACHN (upper panel) and 786-O (lower panel) cells with stable C1QBP knockdown (left panel) and C1QBP overexpression (right panel). The expression of C1QBP and XDH was detected by western blot both in tumors (T) and adjacent normal tissues (N) of 30 primary RCC patients. (C) Representative 8 pairs of western blot images were shown. (D) The expression of C1QBP (left panel) and XDH (right panel) was normalized with β-actin and quantified by Image J software in 30 primary RCC patients. The analysis was used paired t-test, P = 0.015, P < 0.0001, respectively, n = 30. (E) The expression of C1QBP and XDH was examined by immunohistochemistry staining in a study cohort with 57 pairs of RCC (Tumor) and adjacent normal kidney tissues (Para-tumor). Representative pictures were shown, and brown signals indicated positive staining. Scale bar = 50μm. Statistically significant differences were indicated: *, P < 0.05, **, P < 0.01 and ***, P < 0.001.

Application: IHC    Species: Human    Sample: kidney tissues

Figure 2 C1QBP regulates the expression of XDH in RCC. (A) Western blot detected the expression of XDH in ACHN and 786-O cells with stable C1QBP knockdown (left panel) and C1QBP overexpression (right panel). (B) The XDH mRNA was examined by qRT-PCR in ACHN (upper panel) and 786-O (lower panel) cells with stable C1QBP knockdown (left panel) and C1QBP overexpression (right panel). The expression of C1QBP and XDH was detected by western blot both in tumors (T) and adjacent normal tissues (N) of 30 primary RCC patients. (C) Representative 8 pairs of western blot images were shown. (D) The expression of C1QBP (left panel) and XDH (right panel) was normalized with β-actin and quantified by Image J software in 30 primary RCC patients. The analysis was used paired t-test, P = 0.015, P < 0.0001, respectively, n = 30. (E) The expression of C1QBP and XDH was examined by immunohistochemistry staining in a study cohort with 57 pairs of RCC (Tumor) and adjacent normal kidney tissues (Para-tumor). Representative pictures were shown, and brown signals indicated positive staining. Scale bar = 50μm. Statistically significant differences were indicated: *, P < 0.05, **, P < 0.01 and ***, P < 0.001.

限制条款

产品的规格、报价、验证数据请以官网为准，官网链接：www.affbiotech.com | www.affbiotech.cn（简体中文）| www.affbiotech.jp（日本語）

产品的数据信息为Affinity所有，未经授权不得收集Affinity官网数据或资料用于商业用途，对抄袭产品数据的行为我们将保留诉诸法律的权利。

产品相关数据会因产品批次、产品检测情况随时调整，如您已订购该产品，请以订购时随货说明书为准，否则请以官网内容为准，官网内容有改动时恕不另行通知。

Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时，请您在Affinity官方渠道提交售后申请。

产品仅供科学研究使用。不用于诊断和治疗。 

产品未经授权不得转售。

Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.